, Part I, Item 1A. Risk Factors, and Part II, Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations, but are also contained elsewhere in this report. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this report are forward-looking statements. In some cases, you can iden...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001193125-26-093992 | EDGAR | 108K words |
| 2025-03-10 | 2024-12-31 | 0000950170-25-036309 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0000950170-24-027988 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001493152-23-007129 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001493152-22-006520 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001493152-21-005814 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001493152-20-003818 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001493152-19-003335 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001493152-18-003416 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001140361-17-012402 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269599 | EDGAR | 30K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107333 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070378 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127077 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-094004 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056998 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040058 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027552 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001493152-23-016392 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031359 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001493152-22-022085 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001493152-22-013041 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-11 | 0001193125-26-101167 | EDGAR | 1K words |
| 2026-03-05 | 0001193125-26-093948 | EDGAR | — |
| 2025-11-28 | 0001193125-25-302552 | EDGAR | — |
| 2025-11-24 | 0001193125-25-291979 | EDGAR | — |
| 2025-11-12 | 0001193125-25-276249 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269534 | EDGAR | — |
| 2025-08-26 | 0000950170-25-111319 | EDGAR | — |
| 2025-08-12 | 0000950170-25-107314 | EDGAR | — |
| 2025-07-02 | 0000950170-25-093007 | EDGAR | — |
| 2025-06-23 | 0000950170-25-088738 | EDGAR | — |
473 total filings indexed. 441 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000876343 |
| Ticker | LCTX |
| Exchange | NYSE |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | CA |
| Website | https://www.lineagecell.com |
| Listed | 1992-03-05 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report